| Name | Lincare |
|---|---|
| Organization Name | Lincare Inc |
| Location | 28a Pronghorn Trl, Bozeman, Montana 59718 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (406) 585-5582 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNA interference based therapeutic discovery and development, today announced that new preclinical data using proprietary self-delivering RNAi compounds, including RXI-109, will be presented at the Keystone Symposia's Mechanism and Biology of Silencing conference being held March 20-25, 2011 in Monterey, California.
Bowel cancer survival rates could be improved if chemotherapy drugs were delivered via tiny nanoparticles to the diseased organs rather than oral treatment.
Researchers at La Jolla Institute for Allergy & Immunology (LIAI) have identified two molecules (TL and CD8aa) that cooperate to trigger immune cells to develop into long-lived memory cells to fight recurring infections. This finding may have important implications for the future development of longer lasting and more potent vaccines for viruses such as HIV and West Nile.
GTx, Inc. today reported financial results for the first quarter of 2010. The net income for the first quarter ended March 31, 2010 was $44.3 million compared with a net loss of $11.3 million for the same period in 2009. Net income for the current period included the recognition of approximately $54.9 million in collaboration revenue due to the termination of our license and collaboration agreement with Merck & Co., Inc in March 2010.
› Verified 8 days ago
| NPI Number | 1790882165 |
| Organization Name | LINCARE INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 28a Pronghorn Trail, Bozeman, MT 59718 |
| Phone Number | 406-585-5582 |
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNA interference based therapeutic discovery and development, today announced that new preclinical data using proprietary self-delivering RNAi compounds, including RXI-109, will be presented at the Keystone Symposia's Mechanism and Biology of Silencing conference being held March 20-25, 2011 in Monterey, California.
Bowel cancer survival rates could be improved if chemotherapy drugs were delivered via tiny nanoparticles to the diseased organs rather than oral treatment.
Researchers at La Jolla Institute for Allergy & Immunology (LIAI) have identified two molecules (TL and CD8aa) that cooperate to trigger immune cells to develop into long-lived memory cells to fight recurring infections. This finding may have important implications for the future development of longer lasting and more potent vaccines for viruses such as HIV and West Nile.
GTx, Inc. today reported financial results for the first quarter of 2010. The net income for the first quarter ended March 31, 2010 was $44.3 million compared with a net loss of $11.3 million for the same period in 2009. Net income for the current period included the recognition of approximately $54.9 million in collaboration revenue due to the termination of our license and collaboration agreement with Merck & Co., Inc in March 2010.
› Verified 8 days ago
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNA interference based therapeutic discovery and development, today announced that new preclinical data using proprietary self-delivering RNAi compounds, including RXI-109, will be presented at the Keystone Symposia's Mechanism and Biology of Silencing conference being held March 20-25, 2011 in Monterey, California.
Bowel cancer survival rates could be improved if chemotherapy drugs were delivered via tiny nanoparticles to the diseased organs rather than oral treatment.
Researchers at La Jolla Institute for Allergy & Immunology (LIAI) have identified two molecules (TL and CD8aa) that cooperate to trigger immune cells to develop into long-lived memory cells to fight recurring infections. This finding may have important implications for the future development of longer lasting and more potent vaccines for viruses such as HIV and West Nile.
GTx, Inc. today reported financial results for the first quarter of 2010. The net income for the first quarter ended March 31, 2010 was $44.3 million compared with a net loss of $11.3 million for the same period in 2009. Net income for the current period included the recognition of approximately $54.9 million in collaboration revenue due to the termination of our license and collaboration agreement with Merck & Co., Inc in March 2010.
› Verified 8 days ago
Cvs Pharmacy #08621 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 115 North 19th Avenue, Bozeman, Montana 59718 Phone: (406) 587-9252 | |
Rotech Type: Durable Medical Equipment & Medical Supplies Supplier Location: 114 Bridger Center Dr, Bozeman, Montana 59715 Phone: (406) 586-1262 | |
Lincare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 28a Pronghorn Trl, Bozeman, Montana 59718 Phone: (406) 585-5582 | |
Walmart Pharmacy 10-2084 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1500 N 7th Ave, Bozeman, Montana 59715 Phone: (406) 585-8753 | |
Safeway Pharmacy #2999 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1735 W Main Street, Bozeman, Montana 59715 Phone: (406) 585-9155 |